kr836.40
kr-10.00 (-1.18%)
End-of-day quote: 05/01/2024
CPSE:COLO B
Coloplast A/S Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PG | Procter & Gamble | NYSE | Outperform | $163.40 | $166.80 | 0.00% | 5 | $385.65B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $151.18 | $174.55 | 0.00% | 3 | $364.31B |
| PFE | Pfizer | NYSE | Outperform | $27.18 | $32.87 | 0.00% | 6 | $153.91B |
| ULVR | Unilever PLC | LSE | Hold | £41.40 | £50.61 | 0.00% | 12 | £103.61B |
| SAN | Sanofi | ENXTPA | Outperform | 93.08€ | 102.80€ | 0.00% | 9 | 116.22€B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.21 | $58.15 | 0.00% | 10 | $89.62B |
| RKT | Reckitt Benckiser Group | LSE | Outperform | £44.76 | £66.68 | 0.00% | 12 | £31.55B |
| BEI | Beiersdorf | XTRA | Outperform | 140.55€ | 137.41€ | 0.00% | 3 | 31.46€B |
| BAYN | Bayer | XTRA | Hold | 27.35€ | 45.15€ | 0.00% | 4 | 26.87€B |
| CLX | Clorox Co-The | NYSE | Hold | $139.63 | $154.18 | 0.00% | 9 | $17.34B |
| SN. | Smith & Nephew | LSE | Outperform | £9.77 | £16.09 | 0.00% | 10 | £8.54B |
| CTEC | ConvaTec Group PLC | LSE | Outperform | £2.46 | £3.43 | 0.00% | 6 | £5.03B |
| PRGO | Perrigo Co PLC | NYSE | Buy | $32.90 | $44.75 | 0.00% | 0 | $4.43B |
| HYPE3 | Hypera | BOVESPA | Outperform | R$29.52 | R$45.97 | 0.00% | 3 | R$18.69B |
| AXNX | Axonics | NasdaqGS | Hold | $66.87 | $70.15 | 0.00% | 2 | $3.40B |
| IART | Integra LifeSciences Holdings | NasdaqGS | Hold | $29.18 | $46.60 | 0.00% | 4 | $2.29B |
| ORGO | Organogenesis Holdings | NasdaqCM | Outperform | $2.51 | $4.75 | 0.00% | 1 | $311.55M |
| CLGN | CollPlant Biotechnologies | NasdaqGM | Buy | $5.55 | $0.00 | 0.00% | 0 | $65.00M |
| 540468 | KMS Medisurgi | BSE | - | 34.35 | 0.00 | 0.00% | 0 | 113.03M |
